FindTrial
Sign In

Immune ThrombocytoPenia * Before and After Therapy study

Immune ThrombocytoPenia * Before and After Therapy study - ITP - BAT study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON38836
Enrollment
60
Registered
2013-09-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Idiopathic Thrombocytopenic Purpura ITP

Interventions

None listed

Sponsors

Sanquin Bloedbank
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: newly diagnosed, untreated ITP

Exclusion criteria

Exclusion criteria: anders

Design outcomes

Primary

MeasureTime frame
Platelet activity, according to the PATS (P10.127) test and platelet auto-antibodies according to the MAIPA (P12.106).—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)